How we helped Provoc relaunch its clinical-trial recruitment practice.
We built Provoc Research a new website and a clinical-trial intelligence platform that shows where trials are, where patients live, and where the two don't meet.


Provoc has spent 25 years helping health research reach the communities it most often misses. This fall they relaunched Provoc Research, their clinical-trial recruitment practice. We built the two things the relaunch needed: a website that makes Provoc's case to trial sponsors, and a dataset that shows which trials need help and where their patients live.
"Every sponsor tells us the same thing: we need these patients, and we needed them yesterday. Now we can show them where those patients live, which trials near them are competing for the same people, and how we'll reach them. That turns a recruitment plan from a guess into a map."
The problem Provoc solves
Most trials struggle to enroll. By one industry estimate, reported in a 2020 editorial, more than 80% miss their enrollment target dates. A trial that can't enroll can't start, and a trial that enrolls slowly costs more and reaches patients later. Black, Latino, rural, and low-income communities are underrepresented in research, so results serve them less.
Provoc is good at exactly this. They recruit for Phase 2 and Phase 3 trials and start with the hardest-to-reach communities. Their results include:
- 3,059 sign-upsfrom interested Black and Latinx participants for the Gates Medical Research Institute's COVID-19 treatment trial, with three times the share of non-white participants compared with earlier recruitment.
- More than 350,000 membersfor the Alzheimer's Prevention Registry.
- More than 600 respondentsin the first month for the FTD Disorders Registry.
Our job was to help more trial teams see that record, and to point Provoc at the trials that need it most.
What we built: a new provocresearch.com
We designed and built provocresearch.com, which launched in October 2026. It's written for trial sponsors and research teams, and it explains Provoc's method step by step: research with the community, messages and microsites built for the people being asked, outreach through trusted local partners, and steady testing.
- The proof up front.Six case studies, each on its own page, plus summaries of Provoc's published research.
- Fourteen articles moved over.We carried Provoc's best writing over from provoc.me word for word, so years of expertise kept working.
- A clear next step.Trial teams can ask for a consultation or a three-week recruitment assessment, and each request goes straight to Provoc's team.
What we built: a private clinical-trial dataset
We keep a copy of every study in ClinicalTrials.gov, about 600,000 records, and refresh it daily. It records what changed and when: status, phase, eligibility rules, and sites. We joined it to county-level data from the Census Bureau, the CDC, and HRSA, so each trial can be read against how common the condition is, how many people live nearby, and where care is hard to reach.
On top of that, we score each trial for how well it fits what Provoc does best. Trials for common conditions, trials that need diverse patients, and conditions where specialists can refer patients rank higher.
We used AI for what it's good at: reading and sorting hundreds of thousands of records every day. We used people for what they're good at: deciding what makes a trial worth Provoc's time, and how to approach communities that research has let down before. The scoring reflects Provoc's 25 years of judgment, not a guess from a model.
What it lets Provoc do
- Find trials that need help.Status changes, added sites, and slipping dates show which studies are struggling to enroll, often before they ask for help.
- Advise on where to put trial sites.Sites belong where patients with the condition live, not only where the hospital is.
- Plan outreach county by county.Messages and partners can go where need and access meet.
The data narrows the question. It doesn't recruit anyone. Provoc's people do that. What we built makes their method faster and points it where it will do the most good.
Work with us
Provoc had deep expertise and a hard problem: hundreds of thousands of trials, and no way to see which ones needed them most. We turned that into a platform their team uses to decide where to spend its time. That's the work we like best: a complicated problem, a business process that could run far better, and a team that knows its field and needs the right tools.
If that sounds like your organization, let's talk. The first call is free, and you'll leave it knowing whether we can help.
Running a trial that needs patients? Talk to Provoc Research.
Disclosure: Raj Aggarwal, Provoc's founder, is also a partner at Standard Bureau.